CONSTANTINE CANNON, LLP for AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Foreign entity interest: S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN S ANDERSON | — |
| W STEPHEN CANNON | — |
| JOSEPH H GIBSON | — |
Health Issues HCR
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Foreign entity interest: health care reform; drug reimportation; tax on pharmaceutical companies; physicians payments; biosimilar drugs; disposal of drugs; PDUFA reauthorization; health care technical corrections; Life sciences research tax credit legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN S ANDERSON | — |
| W STEPHEN CANNON | — |
| JOSEPH H GIBSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.